Philip D. Gregory
2014 - Sangamo Biosciences
In 2014, Philip D. Gregory earned a total compensation of $1.7M as Senior Vice President, Research and Chief Scientific Officer at Sangamo Biosciences, a 8% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $142,800 |
|---|---|
| Option Awards | $607,343 |
| Salary | $425,000 |
| Stock Awards | $527,625 |
| Total | $1,702,768 |
Gregory received $607.3K in option awards, accounting for 36% of the total pay in 2014.
Gregory also received $142.8K in non-equity incentive plan, $425K in salary and $527.6K in stock awards.
Rankings
In 2014, Philip D. Gregory's compensation ranked 5,216th out of 13,032 executives tracked by ExecPay. In other words, Gregory earned more than 60.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,216 out of 13,032 | 60th |
Division Manufacturing | 1,863 out of 4,967 | 63rd |
Major group Chemicals And Allied Products | 623 out of 1,690 | 63rd |
Industry group Drugs | 475 out of 1,369 | 65th |
Industry Biological Products, Except Diagnostic Substances | 81 out of 241 | 66th |
Source: SEC filing on April 25, 2016.
Gregory's colleagues
We found four more compensation records of executives who worked with Philip D. Gregory at Sangamo Biosciences in 2014.